secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K/A
Filed at:   2023-09-15T23:59:59+00:00
Accession:  0000950170-23-048428
Event type: other
Sentiment:  neutral
Materiality: 0.00
LLM model:  deepseek-v4-flash:cloud@v2

Mind Medicine files 8-K/A to correct jurisdiction of incorporation to British Columbia
--------------------------------------------------------------------------------

- Corrects prior 8-K cover page jurisdiction from erroneous entry to British Columbia, Canada.
- Original Aug 14, 2023 8-K reported a loan agreement with K2 HealthVentures; this amendment does not alter that disclosure.
- No financial, operational, or liquidity impact; purely administrative correction.
- Company continues to trade on Nasdaq under symbol MNMD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000095017023048428/0000950170-23-048428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000095017023048428/mnmd-20230814.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-048428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer